Merck Serono Overview

  • Year Founded
  • 1970

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Open

  • Financing Rounds
  • 3

  • Investments
  • 1

Merck Serono General Information

Description

Manufacturer of gastroenterology medicines and medical supplies based in Geneva, Germany. The company is engaged in making medicines, fertility drugs and other medicinal products for its clients in Germany and other countries.

Contact Information

Website
www.serono.com
Formerly Known As
Serono
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Medical Supplies
Other Devices and Supplies
Acquirer
Merck Biopharma
Primary Office
  • 15bis, chemin des Mines
  • Case postale 54
  • Geneva
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck Serono Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck Serono‘s full profile, request access.

Request a free trial

Merck Serono Patents

  • 3,375

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 97

    Granted

  • 8

    Pending

  • 000

    Expiring in next 12 mo

Merck Serono Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019274782-A1 Method for controlling the afucosylation level of a glycoprotein composition Pending 24-May-2018 0000000000
CA-3099917-A1 Method for controlling the afucosylation level of a glycoprotein composition Pending 24-May-2018 0000000000
EP-3802846-A1 Method for controlling the afucosylation level of a glycoprotein composition Pending 24-May-2018 0000000000
US-20210147532-A1 Method for controlling the afucosylation level of a glycoprotein composition Pending 24-May-2018 0000000000 0
US-20190194151-A1 Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof Inactive 04-Jan-2016 C07D277/06 0
To view Merck Serono’s complete patent history, request access »

Merck Serono Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merck Serono Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sol-Gel Technologies (Sunscreen Business) 24-Jan-2008 0000000000 Personal Products
To view Merck Serono’s complete acquisitions history, request access »